PRESS RELEASE published on 03/12/2026 at 07:25, 3 months 10 days ago Consultation process at Bichsel completed Bichsel completes consultation process, to close pharmaceutical manufacturing operations with reduced job redundancies. Galenica's subsidiary to focus on home care services Galenica Pharmaceutical Manufacturing Consultation Process Redundancies Bichsel
BRIEF published on 03/10/2026 at 06:45, 3 months 12 days ago Galenica Reports Strong 2025 Results and Raises Mid-Term Guidance Sales Growth EBIT Increase Healthcare Services Galenica Results Diagnostics Expansion
BRIEF published on 03/10/2026 at 06:45, 3 months 12 days ago Galenica records solid growth in 2025 and adjusts its forecasts EBIT Growth Diagnosis Galenica Pharmacies
PRESS RELEASE published on 03/10/2026 at 06:40, 3 months 12 days ago Galenica achieves strong annual result and increases mid-term guidance Galenica achieves strong annual results, increasing sales by 5.5% to CHF 4,135.6 million in 2025. Mid-term EBIT guidance raised to CHF 270 million by 2027 Sales Increase Annual Results EBIT Growth Galenica Mid-term Guidance
BRIEF published on 02/24/2026 at 06:45, 3 months 26 days ago Galenica is repositioning its subsidiary Bichsel towards home healthcare Home Care Galenica Social Plan Bichsel Production Closed
BRIEF published on 02/24/2026 at 06:45, 3 months 26 days ago Galenica Restructures Bichsel with Focus on Home Care Services Home Care Services Galenica AG Bichsel Restructuring Job Impact Financial Effects
PRESS RELEASE published on 02/24/2026 at 06:40, 3 months 26 days ago Galenica focuses Bichsel’s business on home care services Galenica's subsidiary Bichsel to focus on home care services and discontinue pharmaceutical production by end of 2026, affecting 170 jobs. Galenica strengthens strategy implementation Galenica Pharmaceutical Production Home Care Services Strategy Implementation Bichsel
BRIEF published on 01/22/2026 at 06:45, 5 months ago Galenica AG Sees Record Sales Growth to Over CHF 4 Billion Financial Performance Sales Growth Galenica Pharmacy Expansion Diagnostics Introduction
BRIEF published on 01/22/2026 at 06:45, 5 months ago Galenica: Historic growth despite a challenging market Dividend Growth Diagnostics Pharmacies Logistics & IT
PRESS RELEASE published on 01/22/2026 at 06:40, 5 months ago Galenica continues to grow: sales increase to over CHF 4 billion Galenica reports sales growth to over CHF 4 billion in 2025, driven by strong demand for prescription drugs and new 'Diagnostics' area. EBIT guidance and dividend expectations confirmed Sales Growth Galenica Diagnostics Prescription Drugs CHF 4 Billion
Published on 06/22/2026 at 21:05, 56 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 2 hours 16 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 6 hours 3 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 6 hours 31 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 7 hours 1 minute ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 21:07, 54 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 1 hour 11 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 1 hour 28 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 2 hours 34 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:54, 3 hours 6 minutes ago EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:00, 4 hours 1 minute ago GUILLEMOT CORPORATION: STATEMENT REGARDING THE PASSING OF Mr. CLAUDE GUILLEMOT, CHAIRMAN OF GUILLEMOT CORPORATION GROUP
Published on 06/22/2026 at 08:30, 13 hours 31 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
